{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:39:27Z","timestamp":1761284367418,"version":"build-2065373602"},"reference-count":68,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"AIRC","doi-asserted-by":"publisher","award":["IG 2021-25920"],"award-info":[{"award-number":["IG 2021-25920"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The cytoskeleton has been described as a regulator of adrenal physiology and tumour behaviour. In the adrenal cortex, both cytoskeletal filaments, by mediating cholesterol transfer to mitochondria, and their binding proteins, such as cofilin and diaphanous-related formin 1 (DIAPH1), have been implicated in modulating steroidogenic processes. Beyond hormone production, the cytoskeleton participates in oncogenic signalling and contributes to the acquisition of malignant behaviour in adrenocortical carcinoma (ACC). Cytoskeleton-associated proteins such as filamin A (FLNA), fascin-1 (FSCN1), RASSF1A, and the guanine nucleotide exchange factor VAV2 are involved in signal transduction, cell cycle regulation, and cytoskeletal remodelling. In ACC, dysregulation of the expression or activity of these proteins correlates with ACC aggressiveness, including increased proliferation, motility, and invasion as well as poor prognosis, making them attractive candidates for targeted therapeutic strategies. To date, no review has systematically addressed the role of cytoskeleton and its binding partners in both adrenal physiological regulation and pathological context. This review is the first to provide a comprehensive overview of cytoskeletal involvement in adrenal cortex function and cancer, highlighting emerging molecular players and their possible therapeutic implications.<\/jats:p>","DOI":"10.3390\/ijms262110348","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:34:38Z","timestamp":1761284078000},"page":"10348","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Cytoskeleton in Adrenal Physiology and Tumours: Functional Roles and Emerging Molecular Targets"],"prefix":"10.3390","volume":"26","author":[{"given":"Rosa","family":"Catalano","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-036X","authenticated-orcid":false,"given":"Emma","family":"Nozza","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"},{"name":"PhD Program in Experimental Medicine, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9238-0367","authenticated-orcid":false,"given":"Emanuela","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2218-9893","authenticated-orcid":false,"given":"Sonia","family":"Di Bari","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"},{"name":"PhD Program in Experimental Medicine, University of Milan, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9065-3886","authenticated-orcid":false,"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"},{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-7895","authenticated-orcid":false,"given":"Erika","family":"Peverelli","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Community Health, Department of Excellence 2023\u20132027, University of Milan, 20122 Milan, Italy"},{"name":"Endocrinology Unit, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature08908","article-title":"Cell mechanics and the cytoskeleton","volume":"463","author":"Fletcher","year":"2010","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.1175862","article-title":"Actin, a central player in cell shape and movement","volume":"326","author":"Pollard","year":"2009","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.biochem.69.1.277","article-title":"Structural insights into microtubule function","volume":"69","author":"Nogales","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2559.1988.tb01951.x","article-title":"Expression of intermediate filament proteins in adrenal cortex and related tumours","volume":"12","author":"Stel","year":"1988","journal-title":"Histopathology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a030288","DOI":"10.1101\/cshperspect.a030288","article-title":"Overview of the Cytoskeleton from an Evolutionary Perspective","volume":"10","author":"Pollard","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1091\/mbc.E19-09-0491","article-title":"New twists in actin-microtubule interactions","volume":"32","author":"Pimm","year":"2021","journal-title":"Mol. Biol. Cell"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Izdebska, M., Zieli\u0144ska, W., Ha\u0142as-Wi\u015bniewska, M., and Grzanka, A. (2020). Involvement of Actin and Actin-Binding Proteins in Carcinogenesis. Cells, 9.","DOI":"10.3390\/cells9102245"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1271521","DOI":"10.3389\/fendo.2023.1271521","article-title":"Harnessing the power of nutritional antioxidants against adrenal hormone imbalance-associated oxidative stress","volume":"14","author":"Patani","year":"2023","journal-title":"Front. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/JME-15-0257","article-title":"60 YEARS OF POMC: Adrenal and extra-adrenal functions of ACTH","volume":"56","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","article-title":"Overview of the 2022 WHO Classification of Adrenal Cortical Tumours","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"bvaa075","DOI":"10.1210\/jendso\/bvaa075","article-title":"Molecular Basis of Primary Aldosteronism and Adrenal Cushing Syndrome","volume":"4","author":"Vaduva","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(24)00378-4","article-title":"Adrenocortical carcinoma: A practical guide for clinicians","volume":"13","author":"Fassnacht","year":"2025","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1016\/S0021-9258(19)44061-1","article-title":"Stimulation of steroid secretion by antimicrotubular agents","volume":"248","author":"Temple","year":"1973","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9080","DOI":"10.1016\/S0021-9258(19)86812-6","article-title":"The role of microfilaments in the response of adrenal tumour cells to adrenocorticotropic hormone","volume":"254","author":"Hall","year":"1979","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1021\/bi00633a021","article-title":"Response of adrenal tumour cells to adrenocorticotropin: Site of inhibition by cytochalasin B","volume":"16","author":"Mrotek","year":"1977","journal-title":"Biochemistry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1083\/jcb.99.4.1335","article-title":"Role of actin in the responses of adrenal cells to ACTH and cyclic AMP: Inhibition by DNase I","volume":"99","author":"Osawa","year":"1984","journal-title":"J. Cell Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0040-8166(89)90001-3","article-title":"Microtubules, organelle transport, and steroidogenesis in cultured adrenocortical tumour cells. 1. An ultrastructural analysis of cells in which basal and ACTH-induced steroidogenesis was inhibited by taxol","volume":"21","author":"Benis","year":"1989","journal-title":"Tissue Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1210\/en.2010-0044","article-title":"RhoA and DIAPH1 mediate adrenocorticotropin-stimulated cortisol biosynthesis by regulating mitochondrial trafficking","volume":"151","author":"Li","year":"2010","journal-title":"Endocrinology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/jcs.97.4.679","article-title":"The role of intermediate filaments in adrenal steroidogenesis","volume":"97","author":"Almahbobi","year":"1990","journal-title":"J. Cell Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2017.07.025","article-title":"Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumour cells","volume":"406","author":"Peverelli","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2020.10.022","article-title":"The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells","volume":"497","author":"Catalano","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Catalano, R., Altieri, B., Angelousi, A., Arosio, M., Bravi, F., Canu, L., Croci, G.A., Detomas, M., Esposito, E., and Ferrante, E. (2023). High Filamin A expression in adrenocortical carcinomas is associated with a favourable tumour behaviour: A European multicentric study. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316573"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/ijc.35239","article-title":"Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas","volume":"156","author":"Esposito","year":"2025","journal-title":"Int. J. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"eaal2464","DOI":"10.1126\/scisignal.aal2464","article-title":"Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion","volume":"10","author":"Ruggiero","year":"2017","journal-title":"Sci. Signal."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2017-00984","article-title":"Assessment of VAV2 expression refines prognostic prediction in adrenocortical carcinoma","volume":"102","author":"Sbiera","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1210\/jc.2018-01717","article-title":"Fascin-1 Is a Novel Prognostic Biomarker Associated with Tumour Invasiveness in Adrenocortical Carcinoma","volume":"104","author":"Poli","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/ijc.34526","article-title":"FSCN1 as a new druggable target in adrenocortical carcinoma","volume":"153","author":"Ruggiero","year":"2023","journal-title":"Int. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12885-019-6389-3","article-title":"Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients","volume":"19","author":"Liang","year":"2019","journal-title":"BMC Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1476-4598-12-87","article-title":"Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma","volume":"12","author":"Korah","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-4165(78)90027-2","article-title":"Mechanisms of corticotropin action in rat adrenal cells. I. The effects of inhibitors of protein synthesis and of microfilament formation on corticosterone synthesis","volume":"542","author":"Crivello","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1083\/jcb.77.2.507","article-title":"Cytochalasin-stimulated steroidogenesis from high density lipoproteins","volume":"77","author":"Cortese","year":"1978","journal-title":"J. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1529\/biophysj.105.074534","article-title":"Nonperturbative chemical imaging of organelle transport in living cells with coherent anti-stokes Raman scattering microscopy","volume":"91","author":"Nan","year":"2006","journal-title":"Biophys. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/1097-4644(20010401)81:1<162::AID-JCB1032>3.0.CO;2-U","article-title":"Mechanism of colchicine-induced steroidogenesis in rat adrenocortical cells","volume":"81","author":"Lee","year":"2001","journal-title":"J. Cell. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1242\/jcs.101.2.383","article-title":"Attachment of steroidogenic lipid droplets to intermediate filaments in adrenal cells","volume":"101","author":"Almahbobi","year":"1992","journal-title":"J. Cell Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0039-128X(96)00179-1","article-title":"The roles of calmodulin, actin, and vimentin in steroid synthesis by adrenal cells","volume":"62","author":"Hall","year":"1997","journal-title":"Steroids"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1091\/mbc.e12-08-0597","article-title":"cAMP-stimulated phosphorylation of diaphanous 1 regulates protein stability and interaction with binding partners in adrenocortical cells","volume":"24","author":"Li","year":"2013","journal-title":"Mol. Biol. Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Relav, L., Doghman-Bouguerra, M., Ruggiero, C., Muzzi, J.C.D., Figueiredo, B.C., and Lalli, E. (2023). Steroidogenic factor 1, a Goldilocks transcription factor from adrenocortical organogenesis to malignancy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043585"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1677\/joe.0.1720583","article-title":"Interdependence of steroidogenesis and shape changes in Y1 adrenocortical cells: Studies with inhibitors of phosphoprotein phosphatases","volume":"172","author":"Whitehouse","year":"2002","journal-title":"J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mce.2012.10.012","article-title":"Cholesterol ester droplets and steroidogenesis","volume":"371","author":"Kraemer","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_40","first-page":"339","article-title":"Cofilin\u2014A protein controlling dynamics of actin filaments","volume":"71","author":"Ostrowska","year":"2017","journal-title":"Post\u0119py Hig. Med. Do\u015bw."},{"key":"ref_41","first-page":"1713","article-title":"Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumours","volume":"83","author":"Boulle","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumours uncovered by DNA microarray analysis","volume":"162","author":"Giordano","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1210\/jc.2008-0065","article-title":"Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumours","volume":"93","author":"Almeida","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s12020-019-01869-1","article-title":"IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer","volume":"64","author":"Feelders","year":"2019","journal-title":"Endocrine"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Blyth, A.J., Kirk, N.S., and Forbes, B.E. (2020). Understanding IGF-II Action through Insights into Receptor Binding and Activation. Cells, 9.","DOI":"10.3390\/cells9102276"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1530\/EO-22-0055","article-title":"Role of filamin A in the pathogenesis of neuroendocrine tumours and adrenal cancer","volume":"2","author":"Treppiedi","year":"2022","journal-title":"Endocr. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/35052082","article-title":"Filamins as integrators of cell mechanics and signalling","volume":"2","author":"Stossel","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4161\/cam.5.2.14401","article-title":"The filamins: Organizers of cell structure and function","volume":"5","author":"Nakamura","year":"2011","journal-title":"Cell Adh. Migr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1523\/JNEUROSCI.0894-12.2012","article-title":"Filamin A regulates neural progenitor proliferation and cortical size through Wee1-dependent Cdk1 phosphorylation","volume":"32","author":"Lian","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-020-00959-2","article-title":"A WEE1 family business: Regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"Cerchione","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ando.2009.02.002","article-title":"A matter of dosage: SF-1 in adrenocortical development and cancer","volume":"70","author":"Doghman","year":"2009","journal-title":"Ann. Endocrinol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/me.2007-0120","article-title":"Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer","volume":"21","author":"Doghman","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumours","volume":"95","author":"Sbiera","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"88257","DOI":"10.18632\/oncotarget.21448","article-title":"VAV2: A novel prognostic marker and a druggable target for adrenocortical carcinoma","volume":"8","author":"Ruggiero","year":"2017","journal-title":"Oncotarget"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1741-7015-11-52","article-title":"Association of fascin-1 with mortality, disease progression and metastasis in carcinomas: A systematic review and meta-analysis","volume":"11","author":"Tan","year":"2013","journal-title":"BMC Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sarantelli, E., Mourkakis, A., Zacharia, L.C., Stylianou, A., and Gkretsi, V. (2023). Fascin-1 in Cancer Cell Metastasis: Old Target-New Insights. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411253"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/path.2894","article-title":"The roles of fascins in health and disease","volume":"224","author":"Hashimoto","year":"2011","journal-title":"J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12253-015-9980-1","article-title":"Filamin A: Insights into its exact role in cancers","volume":"22","author":"Shao","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/ERC-17-0440","article-title":"The next step: Mechanisms driving adrenocortical carcinoma metastasis","volume":"25","author":"Lalli","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"698862","DOI":"10.3389\/fendo.2021.698862","article-title":"Circulating Fascin 1 as a promising prognostic marker in adrenocortical cancer","volume":"12","author":"Cantini","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Esposito, F., Giuffrida, R., Raciti, G., Puglisi, C., and Forte, S. (2021). Wee1 kinase: A potential target to overcome tumour resistance to therapy. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910689"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13228","DOI":"10.1074\/jbc.M111.334524","article-title":"Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase","volume":"287","author":"Cubano","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.mce.2012.11.005","article-title":"Beyond steroidogenesis: Novel target genes for SF-1 discovered by genomics","volume":"371","author":"Lalli","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10555-020-09936-0","article-title":"Targeting the cytoskeleton against metastatic dissemination","volume":"40","author":"Ruggiero","year":"2021","journal-title":"Cancer Metast. Rev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"100052","DOI":"10.1016\/j.bbadva.2022.100052","article-title":"Fascin-1: Updated biological functions and therapeutic implications in cancer biology","volume":"2","author":"Li","year":"2022","journal-title":"BBA Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biopha.2018.10.037","article-title":"Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis","volume":"109","author":"Zeinali","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1593\/neo.04565","article-title":"Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma","volume":"7","author":"Choy","year":"2005","journal-title":"Neoplasia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3748\/wjg.14.595","article-title":"Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB","volume":"14","author":"Shen","year":"2008","journal-title":"World J. Gastroenterol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:36:01Z","timestamp":1761284161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/21\/10348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":68,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262110348"],"URL":"https:\/\/doi.org\/10.3390\/ijms262110348","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}